See more : SHANGHAI BLOOM TECHNOLOGY INC (603325.SS) Income Statement Analysis – Financial Results
Complete financial analysis of Aekyungchemical Co., Ltd. (161000.KS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Aekyungchemical Co., Ltd., a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
- KORE Group Holdings, Inc. (KORE-WT) Income Statement Analysis – Financial Results
- Information Services Group, Inc. (III) Income Statement Analysis – Financial Results
- Intercontinental Exchange, Inc. (0JC3.L) Income Statement Analysis – Financial Results
- ESR Group Limited (1821.HK) Income Statement Analysis – Financial Results
- Sunshine Biopharma, Inc. (SBFM) Income Statement Analysis – Financial Results
Aekyungchemical Co., Ltd. (161000.KS)
About Aekyungchemical Co., Ltd.
Aekyungchemical Co., Ltd. operates as a general chemical company. The company provides general-purpose, and functional and eco-friendly plasticizers; phthalic anhydride, maleic anhydride, and itaconic acids; lubricant base oils; resins for composite materials and coatings; adhesives; polyisocyanate hardner, an isocyanate curing agent; and polyester polyol with aromatic structure and urethane system. It also offers household chemicals, including surfactants, purified glycerin, polymer products, and construction chemicals. In addition, the company provides biodiesel, bio heavy oils, and cathode materials. It operates in South Korea, Vietnam, and China. The company was founded in 1970 and is headquartered in Seoul, South Korea.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,793.74B | 2,176.44B | 1,570.09B | 908.85B | 1,017.02B | 1,031.36B | 959.82B | 867.74B | 912.10B | 1,161.07B | 1,176.14B | 413.89B |
| Cost of Revenue | 1,617.67B | 1,954.29B | 1,412.20B | 802.64B | 921.27B | 932.56B | 828.74B | 740.45B | 833.49B | 1,068.46B | 1,092.89B | 388.76B |
| Gross Profit | 176.07B | 222.15B | 157.89B | 106.21B | 95.75B | 98.80B | 131.08B | 127.30B | 78.61B | 92.61B | 83.26B | 25.13B |
| Gross Profit Ratio | 9.82% | 10.21% | 10.06% | 11.69% | 9.42% | 9.58% | 13.66% | 14.67% | 8.62% | 7.98% | 7.08% | 6.07% |
| Research & Development | 21.07B | 19.32B | 7.86B | 7.05B | 6.73B | 6.92B | 5.24B | 4.79B | 4.69B | 5.36B | 4.90B | 1.26B |
| General & Administrative | 11.07B | 10.45B | 3.77B | 2.93B | 3.80B | 3.77B | 3.90B | 2.84B | 2.86B | 3.28B | 3.72B | 1.44B |
| Selling & Marketing | 42.76B | 45.37B | 28.42B | 21.74B | 22.95B | 23.39B | 34.15B | 33.13B | 28.09B | 29.36B | 31.65B | 8.94B |
| SG&A | 53.83B | 55.82B | 32.19B | 24.67B | 26.75B | 27.16B | 38.05B | 35.96B | 30.95B | 32.65B | 35.36B | 10.38B |
| Other Expenses | 56.10B | 51.92B | 24.57B | 17.01B | 15.43B | 775.34M | -2.02B | -2.32B | 266.05M | 546.13M | -199.22M | 52.17M |
| Operating Expenses | 131.01B | 127.06B | 64.63B | 48.73B | 48.90B | 46.77B | 55.95B | 52.29B | 46.32B | 51.45B | 51.93B | 16.21B |
| Cost & Expenses | 1,748.68B | 2,081.35B | 1,476.83B | 851.36B | 970.17B | 979.34B | 884.69B | 792.73B | 879.81B | 1,119.90B | 1,144.82B | 404.96B |
| Interest Income | 3.29B | 1.23B | 866.45M | 867.41M | 1.79B | 1.57B | 1.41B | 658.26M | 207.57M | 1.05B | 1.26B | 350.13M |
| Interest Expense | 11.60B | 9.29B | 2.81B | 1.35B | 1.79B | 2.49B | 2.15B | 1.97B | 2.29B | 3.82B | 6.59B | 2.49B |
| Depreciation & Amortization | 35.64B | 33.51B | 16.74B | 12.06B | 11.55B | 8.96B | 8.01B | 7.92B | 8.22B | 9.38B | 8.61B | 2.62B |
| EBITDA | 87.99B | 130.18B | 100.72B | 69.45B | 57.25B | 76.25B | 97.56B | 80.46B | 40.84B | 48.19B | 45.09B | 13.79B |
| EBITDA Ratio | 4.91% | 6.32% | 7.68% | 7.72% | 6.08% | 7.41% | 8.56% | 9.21% | 4.91% | 4.26% | 3.96% | 3.19% |
| Operating Income | 45.06B | 95.09B | 93.26B | 57.49B | 46.85B | 52.02B | 75.13B | 75.01B | 32.30B | 41.17B | 31.33B | 8.93B |
| Operating Income Ratio | 2.51% | 4.37% | 5.94% | 6.33% | 4.61% | 5.04% | 7.83% | 8.64% | 3.54% | 3.55% | 2.66% | 2.16% |
| Total Other Income/Expenses | -4.07B | -2.31B | 4.38B | -42.21M | 76.52M | 12.78B | 12.26B | -4.69B | 2.16B | -4.89B | 4.37B | -139.36M |
| Income Before Tax | 40.99B | 92.77B | 97.64B | 57.45B | 46.93B | 64.80B | 87.39B | 70.32B | 34.45B | 36.28B | 35.70B | 8.79B |
| Income Before Tax Ratio | 2.29% | 4.26% | 6.22% | 6.32% | 4.61% | 6.28% | 9.11% | 8.10% | 3.78% | 3.12% | 3.04% | 2.12% |
| Income Tax Expense | 8.02B | 33.41B | 20.35B | 13.12B | 16.56B | 12.07B | 22.66B | 16.95B | 6.50B | 10.07B | 9.08B | 2.03B |
| Net Income | 33.10B | 60.15B | 77.37B | 44.41B | 30.51B | 53.09B | 65.10B | 53.75B | 28.33B | 26.58B | 27.16B | 7.24B |
| Net Income Ratio | 1.85% | 2.76% | 4.93% | 4.89% | 3.00% | 5.15% | 6.78% | 6.19% | 3.11% | 2.29% | 2.31% | 1.75% |
| EPS | 686.27 | 1.25K | 2.30K | 1.41K | 966.47 | 1.68K | 2.05K | 1.68K | 88.50 | 830.00 | 848.00 | 226.00 |
| EPS Diluted | 685.58 | 1.25K | 2.30K | 1.41K | 966.47 | 1.68K | 2.05K | 1.68K | 88.50 | 830.00 | 848.00 | 226.00 |
| Weighted Avg Shares Out | 48.23M | 48.17M | 33.61M | 31.56M | 31.56M | 31.56M | 31.69M | 32.02M | 32.02M | 32.02M | 32.03M | 32.03M |
| Weighted Avg Shares Out (Dil) | 48.28M | 48.19M | 33.64M | 31.57M | 31.56M | 31.56M | 31.69M | 32.03M | 32.02M | 32.02M | 32.03M | 32.03M |
Source: https://incomestatements.info
Category: Stock Reports